Compare LEG & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEG | ATRC |
|---|---|---|
| Founded | 1883 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2018 | 2005 |
| Metric | LEG | ATRC |
|---|---|---|
| Price | $9.84 | $27.54 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $10.50 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 1.1M | 518.7K |
| Earning Date | 04-27-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.01% | N/A |
| EPS Growth | ★ 145.31 | 74.74 |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $5,203,900,000.00 | $201,630,000.00 |
| Revenue This Year | N/A | $15.27 |
| Revenue Next Year | $2.85 | $12.21 |
| P/E Ratio | $5.89 | ★ N/A |
| Revenue Growth | 1.37 | ★ 15.40 |
| 52 Week Low | $6.48 | $27.31 |
| 52 Week High | $13.00 | $43.18 |
| Indicator | LEG | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 42.76 | 33.67 |
| Support Level | $9.26 | N/A |
| Resistance Level | $10.15 | $30.90 |
| Average True Range (ATR) | 0.30 | 1.22 |
| MACD | 0.06 | 0.07 |
| Stochastic Oscillator | 47.42 | 7.04 |
Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the maximum of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.